COVID-19 vaccine drive: RML Hospital resident docs reject Bharat Biotech s Covaxin
ANI
Even as the nation heaved a sigh of relief with much-awaited Covid vaccination drive, resident doctors of Ram Manohar Lohia (RML) Hospital, Delhi have shot a letter to the hospital superintendent saying they do not want to take the Bharat Biotech vaccine â Covaxin. The doctors would instead prefer to take a shot of the Covishield vaccine of Serum Institute of India.
The Resident Doctorsâ Association of RML Hospital stated that doctors are wary of Covaxin since their trials have not been completed. The RML Hospital is one of 81 centres in New Delhi where vaccination drive was held on Saturday.
Doctors of Delhi’s premier RML Hospital have shot a letter to the hospital superintendent saying they do not want to take the Bharat Biotech vaccine – Covaxin – and would instead prefer the Covishield vaccine of Serum Institute of India.
Dr Nirmalya Mohapatra, Vice President of RDA at RML Hospital talking to ANI on Saturday. (Photo/ANI)
RML Resident Doctors Association opposes Bharat Biotech s Covaxin vaccine, cites lack of complete trial ANI | Updated: Jan 16, 2021 22:46 IST
New Delhi [India] January 16 (ANI): As India started its vaccination drive against COVID-19 on Saturday, members of Resident Doctors Association (RDA) at RML hospital here expressed doubts over Covaxin, saying there is lack of complete trial .
Dr Nirmalya Mohapatra, Vice President of RML Hospital RDA said they had come to know that only Coxavin, has been provided to the hospital.
Covaxin is being manufactured by Bharat Biotech in collaboration with ICMR.